ADE as Induction Therapy Results in Treatment of Children With Non-M3 High-Risk Acute Myeloid Leukemia, an Extrapolable Achievement in Developing Countries

Journal of Cancer Therapy
doi 10.4236/jct.2016.73020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc.

Related search

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Anthracycline Versus Non-Anthracycline Induction Regimens in Patients With De Novo Acute Myeloid Leukemia

Middle East Journal of Internal Medicine
2017English

Intesive Fludarabine-High Dose Cytarabine-Idarubicin Combination as Induction Therapy With Risk-Adapted Consolidation May Improve Treatment Efficacy in Younger Acute Myeloid Leukemia (AML) Patients: Rationales, Evidences and Future Perspectives

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2017English

“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2017English

Therapy of Acute Myeloid Leukemia

2012English

Targeted Therapy in Acute Myeloid Leukemia: Aim With Caution

International Journal of Hematologic Oncology
OncologyHematologyPharmacology
2012English

Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy

Cancer
Cancer ResearchOncology
2008English

Kinetics of Bone Marrow Blasts During Induction and Achievement of Complete Remission in Acute Myeloid Leukemia

Haematologica
Hematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy